Comparing protein patterns in extracellular vesicles from different blood vessels in people with ruptured or unruptured brain aneurysms
Official title: Investigation of Protein Heterogeneity in Extracellular Vesicles Derived From Different Human Blood Circulatory Regions
Run by The First Hospital of Jilin University · NCT07439965 · Data updated 2026-11-12
This project tries to see if protein differences in extracellular vesicles taken from different blood vessels can help diagnose or predict outcomes for people with ruptured or unruptured brain aneurysms undergoing neurointerventional procedures.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | The First Hospital of Jilin University Academic / other |
| Locations | 1 site (Changchun, Jilin) |
| Status | Recruiting |
| Started | July 29, 2025 |
| Main results expected | April 2026 |
| Study ends | June 2026 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT07439965 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–60 with a confirmed intracranial aneurysm who are scheduled for neurointerventional treatment under general anesthesia (ruptured cases sampled within three days) and who can give informed consent.
✕Probably not a fit
People older than 60, those with significant preexisting neurological or systemic diseases, a baseline mRS ≥2, or those not undergoing neurointervention are unlikely to be eligible or benefit from this observational protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will collect blood during neurointerventional procedures from the femoral vein, internal jugular vein, and internal carotid artery of adults with ruptured or unruptured intracranial aneurysms. Extracellular vesicles will be isolated from those samples and analyzed with proteomic methods to map protein differences across vascular locations and between hemorrhagic and non-hemorrhagic cases. The study focuses on patients aged 18–60 who are undergoing treatment under general anesthesia, with ruptured cases sampled within three days of symptom onset. As an observational project, there is no treatment intervention; findings aim to identify candidate EV-derived protein biomarkers linked to diagnosis and prognosis.
Why it matters
Potential benefit: If successful, this work could identify blood-based protein markers from specific vascular sites that improve diagnosis and prognosis after subarachnoid hemorrhage.
How similar studies have gone: Prior studies have identified diagnostic signals in extracellular vesicles from peripheral blood, but sampling proteomic heterogeneity across head and neck arterial and venous sites during neurointervention is a novel approach that has not yet been validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\. Aged between 18 and 60 years, regardless of gender; 2. Diagnosed with intracranial aneurysm confirmed by MRA, CTA, or DSA; 3. Patients with aneurysmal subarachnoid hemorrhage must have CT imaging evidence of hemorrhage, and blood collection must occur within 3 days of symptom onset; 4. Scheduled to undergo neurointerventional surgery for intracranial aneurysm under general anesthesia, with the procedure starting between 8:00 AM and 12:00 PM; 5. Willing to comply with the study protocol and data collection procedures; 6. Able to understand and sign the informed consent form. Exclusion Criteria: * 1\. Patients with a pre-onset (in hemorrhagic cases) or preoperative (in non-hemorrhagic cases) Modified Rankin Scale (MRS) score ≥ 2; 2. Presence of other neurological disorders such as Parkinson's disease, Alzheimer's disease, cerebral infarction, brain tumors, epilepsy, etc.; 3. Presence of other systemic diseases such as diabetes, coronary artery disease, cancer, infections, hematological diseases, or severe metabolic disorders that may significantly affect the evaluation of blood EVs; 4. History of severe hepatic or renal dysfunction (ALT \> 3 times the upper limit of normal; creatinine \> 225 μmol/L); 5. Patients who cannot tolerate anesthesia, anticoagulant therapy, or who have coagulation disorders; 6. History of severe allergic reactions to contrast agents; 7. Pregnant women; 8. Patients participating in other clinical trials who have not yet completed follow-up.
Where it's running
-
First Hospital of Jilin University
Changchun, Jilin, China Recruiting
Study contacts
- Study coordinator: Zheng Wan, Medical Doctor, MD
- Email: wanzheng@jlu.edu.cn
- Phone: 86-18743059601
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting unruptured brain aneurysm rupture risk with blood pressure variability and 3D changes
This study follows adults with unruptured intracranial aneurysms who are managed without surgery to see if blood pressure variability and 3D changes in the aneurysm can predict rupture risk using advanced AI.
-
Early complications after flow diverter versus stent-assisted coiling for unruptured wide-neck intracranial bifurcation aneurysms
This real-world study tests which endovascular treatment—flow diverter or stent-assisted coiling—has fewer early complications in adults with unruptured wide-neck bifurcation aneurysms.
-
Early Motor–Cognitive Training after Aneurysmal Subarachnoid Hemorrhage
Aims to see if early motor-cognitive training can improve thinking and movement in adults who recently had an aneurysmal subarachnoid hemorrhage.
-
Gentle ear vagus nerve stimulation to reduce headache after aneurysm stent coiling
This study will try a noninvasive ear vagus nerve stimulation device to see if it reduces postoperative headaches in adults having stent-assisted coiling or flow-diverter treatment for unruptured brain aneurysms.
-
Clinical and economic impact of Sim&Size 3D simulation for planning implants in unruptured intracranial aneurysms
This trial will test whether using Sim&Size 3D simulation software to plan implantable devices reduces complications, procedure time, radiation exposure, and costs for adults having endovascular treatment of unruptured intracranial aneurysms.
-
Preventing delayed brain infarction after aneurysmal subarachnoid hemorrhage with spasmolysis and induced hypertension
This observational project follows adults in intensive care after aneurysmal subarachnoid hemorrhage to see if multimodal neuromonitoring can identify and guide treatment of delayed brain infarction in patients treated with induced hypertension and endoluminal spasmolysis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.